Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) Friday said it has completed acquisition of Natur Produkt International, JSC, for approximately $163 million, plus adjustments for net debt and working capital.
Natur Produkt is a specialty pharmaceutical company in Russia, and has a significant presence in the OTC segment in several categories marketed under the umbrella brand, Natur Produkt.
For comments and feedback: editorial@rttnews.com